ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Hampshire » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NATHANIEL NILES M.D.

Cardiovascular Disease

805

$46.9K

81
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $72

ALAN KONO M.D.

Cardiovascular Disease

775

$30.2K

111
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $72

PATRICK CASSELL M.D.

Cardiovascular Disease

732

$45.2K

85
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $72

ROBERT PALAC MD

Cardiovascular Disease

731

$36.5K

82
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $72

JAMES FLYNN M.D.

Cardiovascular Disease

691

$37.7K

123
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $72

JESSICA SUTHERLAND MD

Cardiovascular Disease

662

$29.7K

89
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $72

DAVID GOLDBERG M.D.

Cardiovascular Disease

630

$37.3K

97
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $72

GERARD DILLON M.D.

Cardiovascular Disease

546

$29.5K

78
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $72

JONATHAN GREENBLATT M.D.

Cardiovascular Disease

519

$28.5K

106
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $72

SALVATORE COSTA M.D.

Cardiovascular Disease

499

$23.2K

58
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $72

TIMOTHY BEAVER MD

Cardiovascular Disease

499

$23K

63
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $72

DAVID PELKOWSKI MD

Cardiovascular Disease

497

$24.2K

69
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $72

BRUCE FRIEDMAN MD

Cardiovascular Disease

496

$35K

49
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 23%

$71
Average prescription price

Avg: $72

RICHARD BOSS M.D.

Cardiovascular Disease

461

$13.9K

69
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 23%

$30
Average prescription price

Avg: $72

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank